Myeloproliferative neoplasm surgery: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}{{AE}} {{MJK}} | {{CMG}}{{AE}} {{MJK}} | ||
==Overview== | ==Overview== | ||
Surgical intervention is recommended for the management of chronic myelogenous leukemia in case of [[ | Surgical intervention is recommended for the management of chronic myelogenous leukemia in case of [[splenomegaly]].<ref>{{Cite journal | ||
| author = [[A. Schmoldt]], [[H. F. Benthe]] & [[G. Haberland]] | | author = [[A. Schmoldt]], [[H. F. Benthe]] & [[G. Haberland]] | ||
| title = Digitoxin metabolism by rat liver microsomes | | title = Digitoxin metabolism by rat liver microsomes | ||
| Line 15: | Line 15: | ||
}}</ref> | }}</ref> | ||
==Surgery== | ==Surgery== | ||
Surgical intervention is recommended for the management of chronic myelogenous leukemia in case of [[ | Surgical intervention is recommended for the management of chronic myelogenous leukemia in case of [[splenomegaly]].<ref>{{Cite journal | ||
| author = [[A. Schmoldt]], [[H. F. Benthe]] & [[G. Haberland]] | | author = [[A. Schmoldt]], [[H. F. Benthe]] & [[G. Haberland]] | ||
| title = Digitoxin metabolism by rat liver microsomes | | title = Digitoxin metabolism by rat liver microsomes | ||
Revision as of 19:48, 6 November 2015
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm surgery On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm surgery |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]
Overview
Surgical intervention is recommended for the management of chronic myelogenous leukemia in case of splenomegaly.[1]
Surgery
Surgical intervention is recommended for the management of chronic myelogenous leukemia in case of splenomegaly.[2]
References
- ↑ A. Schmoldt, H. F. Benthe & G. Haberland (1975). "Digitoxin metabolism by rat liver microsomes". Biochemical pharmacology. 24 (17): 1639–1641. PMID 10. Unknown parameter
|month=ignored (help) - ↑ A. Schmoldt, H. F. Benthe & G. Haberland (1975). "Digitoxin metabolism by rat liver microsomes". Biochemical pharmacology. 24 (17): 1639–1641. PMID 10. Unknown parameter
|month=ignored (help)